Literature DB >> 16236846

Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem.

James K Stoller1, Robert A Sandhaus, Gerard Turino, Ryan Dickson, Keith Rodgers, Charlie Strange.   

Abstract

BACKGROUND AND STUDY
OBJECTIVES: Alpha1-antitrypsin (AAT) deficiency is common but under-recognized. A 1994 mail survey showed a long delay between the onset of symptoms and the initial diagnosis of AAT deficiency. In 2003, we carried out a similar mail survey of AAT-deficient individuals to determine whether any delay in diagnosis experienced by individuals with a more recent diagnosis had become shorter. We also determined whether individuals living near medical centers with an expressed interest in AAT deficiency experienced shorter diagnostic delays than those living at a distance.
METHODS: Results from mail surveys of two different cohorts were compared: a 1994 survey of 304 individuals with severe AAT deficiency and a 2003 survey of 1,953 AAT-deficient individuals. In the 2003 survey cohort, diagnostic delay intervals were analyzed by calendar year of initial diagnosis, rural vs urban residence, visit to a liver or lung specialist within the last year, and living within 50 miles of a medical center with particular expertise in AAT deficiency. One thousand nine hundred fifty-three individuals responded to the 2003 mail survey (37.4%).
RESULTS: In the 2003 cohort, the mean +/- SD diagnostic delay was 5.6 +/- 8.5 years, compared with 7.2 +/- 8.3 years for the 1994 cohort (p = 0.002). In the 2003 cohort, younger patients and male patients experienced shorter diagnostic delays than older patients and female patients (p < 0.0001 and p = 0.007, respectively). For example, the delay was 6.5 +/- 8.8 years for those born in the 1940s, as compared with 0.43 +/- 1.08 years for those born after 1980. Neither urban residence nor living near a center with expertise in AAT deficiency were associated with a shortened diagnostic delay interval.
CONCLUSIONS: Although these results show some improvement in the mean diagnostic delay in the 9-year period separating the two studies, under-recognition of AAT deficiency persists. Diagnostic delay of AAT deficiency is longer in women and in older individuals. Educational efforts are underway to enhance clinicians' diagnostic suspicion of AAT deficiency and permit earlier diagnosis and attendant benefits.

Entities:  

Mesh:

Year:  2005        PMID: 16236846     DOI: 10.1378/chest.128.4.1989

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  51 in total

Review 1.  Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease.

Authors:  Sarah K Brode; Simon C Ling; Kenneth R Chapman
Journal:  CMAJ       Date:  2012-07-03       Impact factor: 8.262

2.  Classifying married adults diagnosed with alpha-1 antitrypsin deficiency based on spousal communication patterns using latent class analysis: insights for intervention.

Authors:  Rachel A Smith; Sara E Wienke; Michelle K Baker
Journal:  J Genet Couns       Date:  2013-11-01       Impact factor: 2.537

3.  Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.

Authors:  Charlie Strange; Robert M Senior; Frank Sciurba; Scott O'Neal; Alison Morris; Stephen R Wisniewski; Russell Bowler; Harry S Hochheiser; Michael J Becich; Yingze Zhang; Joseph K Leader; Barbara A Methé; Naftali Kaminski; Robert A Sandhaus
Journal:  Ann Am Thorac Soc       Date:  2015-10

4.  Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.

Authors:  James K Stoller; Loutfi S Aboussouan; Richard E Kanner; Laura A Wilson; Phil Diaz; Robert Wise
Journal:  Ann Am Thorac Soc       Date:  2015-12

5.  The Alpha-1 Association Genetic Counseling Program: an innovative approach to service.

Authors:  Dawn McGee; Charlie Strange; Rebecca McClure; Laura Schwarz; Marlene Erven
Journal:  J Genet Couns       Date:  2011-03-19       Impact factor: 2.537

Review 6.  Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?

Authors:  Diana Crossley; Robert Stockley; Elizabeth Sapey
Journal:  Drugs Aging       Date:  2019-09       Impact factor: 3.923

7.  Don't Miss the BoAAT: Correctly Diagnosing Acute-on-Chronic Liver Disease.

Authors:  Zain A Sobani; Graziella R Paniz; Morgan Wong; Denis M McCarthy
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

8.  Hidden burden of osteoporosis in alpha-1 antitrypsin deficiency.

Authors:  Emanuela Filipas; Iain Southern; Pooja Khanna; Ritwik Banerjee
Journal:  BMJ Case Rep       Date:  2018-06-27

Review 9.  Pharmacogenomics of chronic obstructive pulmonary disease.

Authors:  Craig P Hersh
Journal:  Expert Rev Respir Med       Date:  2019-04-08       Impact factor: 3.772

10.  [Alpha1-antitrypsin deficiency in Austria: analysis of the Austrian Alpha1-international-registry database].

Authors:  Florian Huber; Karin Schmid-Scherzer; Felix Wantke; Sophie Frantal; Meinhard Kneussl
Journal:  Wien Klin Wochenschr       Date:  2010-07-14       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.